Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 998-1007

  Haan, Serge ^a,b   Margue, Christiane ^a   Engrand, Arnaud ^a   Rolvering, Catherine ^a   Schmitz Van De Leur, Hildegard ^b   Heinrich, Peter C ^b   Behrmann, Iris ^a   Haan, Claude ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; EZRIN; GAMMA INTERFERON; JANUS KINASE 1; MOESIN; RADIXIN; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MUTAGENESIS; MUTANT; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; HUMANS; INTERFERON TYPE II; JANUS KINASE 1; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOKINE; RECEPTORS, INTERFERON;

EID: 40449121624     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.998     Document Type: Article

References (38)

1. Behrmann, I., T. Smyczek, P. C. Heinrich, H. Schmitz-Van de Leur, W. Komyod, B. Giese, G. Müller-Newen, S. Haan, and C. Haan. 2004. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak receptor complex to be equivalent to a receptor tyrosine kinase. J. Biol. Chem. 279: 35486-35493.
2. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
3. Heinrich, P. C., I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374: 1-20.
4. Saharinen, P., K. Takaluoma, and O. Silvennoinen. 2000. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol. 20: 3387-3395.
5. Yeh, T. C., E. Dondi, G. Uze, and S. Pellegrini. 2000. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling. Proc. Natl. Acad. Sci. USA 97: 8991-8996.
6. Girault, J. A., G. Labesse, J. P. Mornon, and I. Callebaut. 1998. Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction. Mol. Med. 4: 751-769.
7. Radtke, S., S. Haan, A. Jörissen, H. M. Hermanns, S. Diefenbach, T. Smyczek, H. Schmitz-Van de Leur, P. C. Heinrich, I. Behrmann, and C. Haan. 2005. The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression. J. Biol. Chem. 280: 25760-25768.
8. Haan, C., H. Is'harc, H. M. Hermanns, H. Schmitz-Van de Leur, I. M. Kerr, P. C. Heinrich, J. Grötzinger, and I. Behrmann. 2001. Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. J. Biol. Chem. 276: 37451-37458.
9. Hilkens, C. M., H. Is'harc, B. F. Lillemeier, B. Strobl, P. A. Bates, I. Behrmann, and I. M. Kerr. 2001. A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130. FEBS Lett. 505: 87-91.
10. Giese, B., C. K. Au-Yeung, A. Herrmann, S. Diefenbach, C. Haan, A. Küster, S. B. Wortmann, C. Roderburg, P. C. Heinrich, I. Behrmann, and G. Müller-Newen. 2003. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J. Biol. Chem. 278: 39205-39213.
11. Siewert, E., W. Müller-Esterl, R. Starr, P. C. Heinrich, and F. Schaper. 1999. Different protein turnover of interleukin-6-type cytokine signalling components. Eur. J. Biochem. 265: 251-257.
12. Pearson, M. A., D. Reczek, A. Bretscher, and P. A. Karplus. 2000. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259-270.
13. Hamada, K., T. Shimizu, T. Matsui, S. Tsukita, and T. Hakoshima. 2000. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19: 4449-4462.
14. Han, B. G., W. Nunomura, Y. Takakuwa, N. Mohandas, and B. K. Jap. 2000. Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization. Nat. Struct. Biol. 7: 871-875.
15. Ceccarelli, D. F., H. K. Song, F. Poy, M. D. Schaller, and M. J. Eck. 2006. Crystal structure of the FERM domain of focal adhesion kinase. J. Biol. Chem. 281: 252-259.
16. Kang, B. S., D. R. Cooper, Y. Devedjiev, U. Derewenda, and Z. S. Derewenda. 2002. The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product. Acta Crystallogr. D. Biol. Crystallogr. 58: 381-391.
17. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8: 52-56, 29.
18. Carson, M. 1997. Macromolecular crystallography. Methods Enzymol. 277: 493-505.
19. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
20. Rost, B., and J. Liu. 2003. The PredictProtein server. Nucleic Acids Res. 31: 3300-3304.
21. Hamada, K., T. Shimizu, S. Yonemura, S. Tsukita, S. Tsukita, and T. Hakoshima. 2003. Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex. EMBO J. 22: 502-514.
22. Briscoe, J., N. C. Rogers, B. A. Witthuhn, D. Watling, A. G. Harpur, A. F. Wilks, G. R. Stark, J. N. Ihle, and I. M. Kerr. 1996. Kinase-negative mutants of JAK1 can sustain interferon-γ-inducible gene expression but not an antiviral state. EMBO J. 15: 799-809.
23. Haan, C., and I. Behrmann. 2007. A cost-effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J. Immunol. Methods 318: 11-19.
24. Radtke, S., H. M. Hermanns, C. Haan, H. Schmitz-Van de Leur, H. Gascan, P. C. Heinrich, and I. Behrmann. 2002. Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. J. Biol. Chem. 277: 11297-11305.
25. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16: 10881-10890.
26. Haan, C., P. C. Heinrich, and I. Behrmann. 2002. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation. Biochem. J. 361: 105-111.
27. Steiner, E., K. Holzmann, C. Pirker, L. Elbling, M. Micksche, H. Sutterluty, and W. Berger. 2006. The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals. J. Cell Sci. 119: 459-469.
28. + interferon-γ- induced apoptosis in primary pancreatic β-cells. J. Biol. Chem. 280: 33984-33991.
29. Giordanetto, F., and R. T. Kroemer. 2002. Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Eng. 15: 727-737.
30. Macchi, P., A. Villa, S. Giliani, M. G. Sacco, A. Frattini, F. Porta, A. G. Ugazio, J. A. Johnston, F. Candotti, J. J. O'Shea, et al. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377: 65-68.
31. Cacalano, N. A., T. S. Migone, F. Bazan, E. P. Hanson, M. Chen, F. Candotti, J. J. O'Shea, and J. A. Johnston. 1999. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J. 18: 1549-1558.
32. Haan, C., S. Kreis, C. Margue, and I. Behrmann. 2006. Jaks and cytokine receptors-an intimate relationship. Biochem. Pharmacol. 72: 1538-1546.
33. Zhou, Y. J., M. Chen, N. A. Cusack, L. H. Kimmel, K. S. Magnuson, J. G. Boyd, W. Lin, J. L. Roberts, A. Lengi, R. H. Buckley, et al. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell 8: 959-969.
34. Funakoshi-Tago, M., S. Pelletier, T. Matsuda, E. Parganas, and J. N. Ihle. 2006. Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J. 25: 4763-4772.
35. Chen, M., A. Cheng, F. Candotti, Y. J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea. 2000. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20: 947-956.
36. Hermanns, H. M., S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann. 2000. Non-redundant signal transduction of interleukin-6-type cytokines: the adapter protein Shc is specifically recruited to rhe oncostatin M receptor. J. Biol. Chem. 275: 40742-40748.
37. Heinrich, P. C., I. Behrmann, G. Müller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334: 297-314.
38. Al-Obeidi, F. A., and K. S. Lam. 2000. Development of inhibitors for protein tyrosine kinases. Oncogene 19: 5690-5701.